Peritoneal ultrafiltration dialysis: enhanced urea transfer using hypertonic peritoneal dialysis fluid.
作者信息
Henderson L W
出版信息
J Clin Invest. 1966 Jun;45(6):950-5. doi: 10.1172/JCI105410.
Abstract
摘要
相似文献
1
Peritoneal ultrafiltration dialysis: enhanced urea transfer using hypertonic peritoneal dialysis fluid.腹膜超滤透析：使用高渗腹膜透析液增强尿素转运
J Clin Invest. 1966 Jun;45(6):950-5. doi: 10.1172/JCI105410.
2
Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.使用高渗腹膜透析液后腹膜通透性的改变。
J Clin Invest. 1969 Jun;48(6):992-1001. doi: 10.1172/JCI106080.
3
[Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program].[高渗交换腹膜平衡试验：在腹膜透析项目中的实际应用]
Nefrologia. 2001 Jul-Aug;21(4):362-9.
4
5
Peritoneal transfer during maximal hyperosmotic ultrafiltration in the rat.大鼠最大渗透超滤过程中的腹膜转运
ASAIO J. 1993 Jan-Mar;39(1):66-70.
6
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.2.27%和3.86%葡萄糖透析液的腹膜平衡试验比较
J Nephrol. 2005 Jan-Feb;18(1):67-71.
7
Differences in peritoneal equilibration test results in patients aged above or below 60 years.60岁及以上或以下患者腹膜平衡试验结果的差异。
Adv Perit Dial. 2002;18:33-9.
8
[Transport processes--ultrafiltration in peritoneal dialysis].[转运过程——腹膜透析中的超滤]
Srp Arh Celok Lek. 1996;124 Suppl 1:159-62.
9
Amphotericin B does not increase peritoneal fluid removal.两性霉素B不会增加腹腔积液的清除。
Adv Perit Dial. 1998;14:3-10.
10
[Ultrafiltration characteristics of peritoneal dialysis].[腹膜透析的超滤特性]
Vnitr Lek. 1983 Mar;29(3):230-7.
引用本文的文献
1
Peritoneal Protein Loss Is Not Associated With Sarcopenia in Peritoneal Dialysis Patients.腹膜蛋白丢失与腹膜透析患者的肌肉减少症无关。
Front Med (Lausanne). 2021 Jul 14;8:653807. doi: 10.3389/fmed.2021.653807. eCollection 2021.
2
Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury.急性腹膜透析治疗新型冠状病毒肺炎相关急性肾损伤
Clin Kidney J. 2020 Jun 30;13(3):269-273. doi: 10.1093/ckj/sfaa102. eCollection 2020 Jun.
3
Effect of hyperosmolar peritoneal dialysis fluid on the elimination of small- and medium-molecular substances.高渗腹膜透析液对中小分子物质清除的影响。
Int Urol Nephrol. 1983;15(2):187-94. doi: 10.1007/BF02085451.
4
Sodium uptake in peritoneal dialysis.腹膜透析中的钠摄取
Br Med J. 1967 Aug 5;3(5561):345-7. doi: 10.1136/bmj.3.5561.345.
5
Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.使用高渗腹膜透析液后腹膜通透性的改变。
J Clin Invest. 1969 Jun;48(6):992-1001. doi: 10.1172/JCI106080.
6
[Influence of dialysate osmolarity on the effectiveness of peritoneal dialysis].
Klin Wochenschr. 1971 May;49(10):583-7. doi: 10.1007/BF01485330.
7
Influence of antidiuretic hormone on peritoneal membrane area and permeability.抗利尿激素对腹膜面积和通透性的影响。
J Clin Invest. 1971 Nov;50(11):2437-43. doi: 10.1172/JCI106742.
8
The clearance of urea and sucrose from isotonic and hypertonic fluids perfused through the ventriculo-cisternal system.
Exp Brain Res. 1974 Apr 30;20(1):18-31. doi: 10.1007/BF00239015.
9
Effect of papaverine on solute transport in peritoneal dialysis.罂粟碱对腹膜透析中溶质转运的影响。
Int Urol Nephrol. 1989;21(1):119-23. doi: 10.1007/BF02549910.
本文引用的文献
1
THE CLINICAL APPLICATION AND TECHNIQUE OF PERITONEAL DIALYSIS.腹膜透析的临床应用与技术
GP. 1963 Nov;28:98-109.
Zotero 插件